The financial impact of the first variance to eliminate RIBA supplemental testing for HCV-NAT positive donors

被引：0

|

作者：

Pratt, ML ^{[1
]}

Thomas, KJ ^{[1
]}

机构：

[1] Floridas Blood Ctrs, Orlando, FL USA

来源：

TRANSFUSION | 2005年 / 45卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：184A / 184A

页数：1

相关论文

共 5 条

[1] Supplemental testing for HCV: To what extent could nucleic acid amplification testing (NAT) replace HCV RIBA 3.0?
Valinsky, JE
Bianco, C
[J]. TRANSFUSION, 2000, 40 (10) : 32S - 32S
[2] HCV EIA and RIBA 3.0 seroreversion among subjects in a follow-up study of HCV seropositive blood donors who tested positive or negative for HCV RNA by minipool-NAT screening
Tobler, L. H.
Murphy, E. L., III
Bahrami, S. H.
Lewithan, P. M.
Andrews, W. W.
Ziermann, R.
Busch, M. P.
[J]. TRANSFUSION, 2007, 47 (03) : 30A - 30A
[3] Utilization of Kidneys from Deceased Donors with Positive Hepatitis C Nucleic Acid Amplification Testing (HCV NAT plus )
King, K. L.
Husain, S. A.
Mohan, S.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 421 - 421
[4] Impact of Transplanting Hepatitis C Nucleic Acid Testing Positive (NAT plus ) Donors to Hepatitis C Virus NAT- Cardiothoracic Recipients
Hudson, M.
Webb, A.
Logan, A.
Silverman, A.
Brueckner, A.
[J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S372 - S372
[5] NAT Yield from Real Time Testing of Organ Donors for HIV-1 RNA and HCV RNA - Safer Organs and No False Positive Results
Chinchilla-Reyes, C.
Mone, T. D.
Johnson, M.
Niles, P.
Nowicki, M. J.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 142 - 142